Halozyme Therapeutics Aktie
47,84
EUR
+0,25
EUR
+0,53
%
54,52
USD
+0,78
USD
+1,45
%
Werbung
Halozyme Therapeutics Aktie Analyse
15.11.24 | Halozyme Therapeutics Neutral | JP Morgan Chase & Co. | |
27.09.12 | Halozyme Therapeutics neutral | UBS AG | |
12.08.08 | Halozyme Therapeutics hold | Brean Murray, Carret & Co., LLC |
Werbung
Werbung